本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2008/4/231 分钟阅读
New Animal Drugs; Enrofloxacin
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for use of enrofloxacin injectable solution in swine for the treatment and control of respiratory disease.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →